Rithm Capital Corp. Chief Legal Officer Philip M. Sivin filed a Form 4 on October 30, 2026, disclosing the acquisition of 2,267 Class B Profits Units of Rithm Capital Management LLC across five separate tranches, all recorded as dividend equivalent rights accrued on previously …
Director Vicente Falconi Campos filed a Form 4 with the SEC on November 3, 2026, disclosing the conversion of Class "C" Preferred Shares into Common Shares of AXIA Energia S.A. (AXIA3) on October 30, 2026.
Director Janet H. Kennedy of Duluth Holdings Inc. filed a statement of changes in beneficial ownership on November 3, 2026, reporting the acquisition of 3,410 shares of Class B Common Stock on November 1, 2026.
Director and 10% owner Fred Faching Chang filed a Form 4 with the SEC on November 3, 2026, disclosing two open-market sales of Newegg Commerce, Inc. common shares totaling 7,164 shares on October 30 and November 2, 2026.
Kevin Holleran, President and CEO of Hayward Holdings, Inc., filed a Form 4 on November 3, 2026, disclosing the exercise of stock options and the sale of 50,000 shares of common stock on November 2, 2026, pursuant to a Rule 10b5-1 trading plan.
Cytokinetics Inc EVP of Research and Development Fady Ibraham filed a Form 4 on November 3, 2026, disclosing the exercise of 3,500 stock options and the same-day sale of 3,500 shares of common stock under a Rule 10b5-1 plan.
Director Stephen A. Nolan of Quest Resource Holding Corp filed a Form 4 on November 3, 2026, disclosing the acquisition of 3,211 restricted stock units on October 31, 2026, under the company's 2024 Incentive Compensation Plan.
Director Mercedes Johnson filed a Form 4 with the SEC on November 3, 2026, disclosing the sale of 166 shares of Teradyne, Inc. common stock on November 2, 2026, under a Rule 10b5-1 trading plan.
XCF Global, Inc. Chief Financial Officer and Director Wray T. Thorn filed a Form 4 on November 3, 2026, disclosing the acquisition of 20,162,374 shares of restricted Class A Common Stock on October 30, 2026, at a price of $0 per share.
Director Jonathan A. Levy filed a Form 4 with the SEC on November 3, 2026, disclosing a purchase of Renasant Corp common stock on November 2, 2026.